Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,719.31
1,260.77
1,052.64
1,241.73
996.98
740.23
860.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,719.31
1,260.77
1,052.64
1,241.73
996.98
740.23
860.80
Raw Material Cost
1,121.31
719.00
523.51
603.99
545.99
342.37
345.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
165.65
153.31
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
31.27
7.57
5.32
4.54
12.65
7.90
2.59
Selling and Distribution Expenses
152.65
132.93
130.17
134.65
105.72
102.87
132.66
Other Expenses
-11.73
-11.21
3.30
4.20
2.70
1.97
2.52
Total Expenditure (Excl Depreciation)
1,353.61
900.71
692.03
785.14
691.33
472.83
505.55
Operating Profit (PBDIT) excl Other Income
365.7
360.09999999999997
360.6
456.59999999999997
305.7
267.4
355.3
Other Income
12.39
45.67
27.80
20.20
9.20
12.60
12.31
Operating Profit (PBDIT)
485.26
474.31
455.02
537.38
362.95
310.05
402.62
Interest
31.27
7.57
5.32
4.54
12.65
7.90
2.59
Exceptional Items
8.92
53.59
0.04
0.01
-9.33
1.32
2.14
Gross Profit (PBDT)
598.00
541.77
529.13
637.73
450.99
397.86
515.72
Depreciation
105.21
70.12
63.96
71.41
48.93
43.20
34.75
Profit Before Tax
357.71
450.20
385.78
461.43
292.04
260.27
367.42
Tax
46.48
52.82
57.40
58.87
41.55
38.51
60.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
209.77
391.76
328.38
402.57
250.49
221.75
306.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
209.77
391.76
328.38
402.57
250.49
221.75
306.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
97.32
5.62
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
307.09
397.38
328.38
402.57
250.49
221.75
306.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,387.98
1,834.98
1,636.72
1,461.27
1,049.66
988.28
1,033.47
Earnings per share (EPS)
0.3
0.55
0.48
0.61
0.36
0.31
0.43
Diluted Earnings per share
0.3
0.55
0.48
0.61
0.36
0.31
0.43
Operating Profit Margin (Excl OI)
21.38%
28.44%
34.51%
35.9%
30.57%
34.35%
41.31%
Gross Profit Margin
26.92%
41.27%
42.72%
42.91%
34.2%
41.0%
46.72%
PAT Margin
12.2%
31.07%
31.2%
32.42%
25.13%
29.96%
35.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 36.37% vs 19.78% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -22.72% vs 21.01% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 10.34% vs 0.33% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 311.84% vs 43.40% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Dalian Bio-Chem Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,719.31
0
1,719.31
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,719.31
0
1,719.31
Raw Material Cost
1,121.31
0
1,121.31
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
165.65
0
165.65
Power Cost
0
0
0.00
Manufacturing Expenses
31.27
0
31.27
Selling and Distribution Expenses
152.65
0
152.65
Other Expenses
-11.73
0.00
-11.73
Total Expenditure (Excl Depreciation)
1,353.61
0
1,353.61
Operating Profit (PBDIT) excl Other Income
365.70
0.00
365.70
Other Income
12.39
0
12.39
Operating Profit (PBDIT)
485.26
0
485.26
Interest
31.27
0
31.27
Exceptional Items
8.92
0
8.92
Gross Profit (PBDT)
598.00
0
598.00
Depreciation
105.21
0
105.21
Profit Before Tax
357.71
0
357.71
Tax
46.48
0
46.48
Provisions and contingencies
0
0
0.00
Profit After Tax
209.77
0
209.77
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
209.77
0
209.77
Share in Profit of Associates
0
0
0.00
Minority Interest
97.32
0
97.32
Other related items
0.00
0.00
0.00
Consolidated Net Profit
307.09
0
307.09
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,387.98
0
1,387.98
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.30
0
0.30
Operating Profit Margin (Excl OI)
21.38%
0%
0.00
21.38%
Gross Profit Margin
26.92%
0%
0.00
26.92%
PAT Margin
12.20%
0%
0.00
12.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 171.93 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 36.37% vs 19.78% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 30.71 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -22.72% vs 21.01% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.34% vs 0.33% in Dec 2024
Annual - Interest
Interest 3.13 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 311.84% vs 43.40% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.38%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






